How much does a box of ibrutinib/ibrutinib cost?

Ibrutinib/Ibrutinib contains the active ingredient ibrutinib, a drug used to treat adult patients with blood cancers that include those who have not responded to prior treatment or who are undergoing treatment Patients with relapsed mantle cell lymphoma (MCL), patients with previously treated and untreated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and patients with Waldenströ macroglobulinemia (also known as lymphoplasmacytic lymphoma).

For the treatment ofMCL, patients can take ibrutinib alone. For the treatment of CLL, ibrutinib can be taken alone, but can also be taken with bendamustine and rituximab, or with obinutuzumab, rituximab, or venetoclax. For patients with Waldenströ macroglobulinemia, ibrutinib can be used alone or in combination with rituximab.

The original drug of ibrutinib is marketed in the form of capsule preparations in China, and has also been included in the reimbursement scope of Class B medical insurance. Reimbursement is limited to patients who meet the indications. The common specificationsThe price of 140mg*90 capsules per box may be around 10,000 yuan, while the price of the original drug listed overseas may be more than 10,000 US dollars per box, which is more expensive. Generic drugs of ibrutinib are also produced and sold overseas in many countries. The drug ingredients are basically the same as those of the original drugs sold domestically and abroad. They may include Bangladeshi version, Indian version, Laos version, etc. The price of each box may range from a few hundred to 1,000 yuan (the price may fluctuate due to the exchange rate).